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OBJECTIVES We sought to test the hypothesis that cytokines would be expressed in the myocardium of
infants with congenital cardiac defects and to identify the signaling pathways involved.
BACKGROUND Mechanical stress upregulates pro-inflammatory cytokines in the myocardium.
METHODS Fifteen infants with tetralogy of Fallot (TOF) (n  7) or with ventricular septal defects
(VSDs) (n  8) were investigated. Concentrations of pro- and anti-inflammatory cytokines
and of the inducible nitric oxide synthase (iNOS) were measured by enzyme-linked
immunosorbent assay and/or Western blotting in the right ventricular myocardium taken
during cardiac surgery. Activation of the nuclear factor-kappa-B (NF-kappa-B) and p38
mitogen-activated protein kinase (MAPK) pathways was assessed by electrophoretic mobility
shift assay with supershift and/or Western blotting, respectively.
RESULTS The pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1-beta,
and IL-6 and the anti-inflammatory cytokine IL-10 were detected in the myocardium of all
patients. Concentrations of the pro-inflammatory cytokines and also of phosphorylated p38
MAPK were higher in patients with TOF than in those with VSD and correlated with the
degree of pressure overload of the right ventricle. Levels of phosphorylated I-kappa-B-alpha,
iNOS, and IL-10 were similar in patients with TOF and in those with VSD.
CONCLUSIONS Our results show intramyocardial synthesis of pro-inflammatory cytokines in infants with
congenital cardiac defects. This is associated with activation of both the NF-kappa-B and p38
MAPK pathways. The latter could be particularly important for the transduction of
mechanical signals in the infant’s myocardium. Synthesis of IL-10 indicates an intramyocar-
dial anti-inflammatory potential in this age group. (J Am Coll Cardiol 2003;41:2266–74)
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Tumor necrosis factor (TNF)-alpha is an important pro-
inflammatory cytokine that belongs to the repertoire of
response to injury (1). The nuclear factor kappa-B (NF-
kappa-B) family of nuclear transcription factors is critical for
the synthesis of TNF-alpha and also for TNF-alpha–
induced secondary mediators of inflammation, such as
interleukin (IL)-1-beta, IL-6, and inducible nitric oxide
synthase (iNOS) (2). The p38 mitogen-activated protein
kinase (MAPK) signaling pathway is another pathway
involved in intracellular signaling and in the regulation of
the production of pro-inflammatory cytokines (3). Stimuli
such as mechanical strain (4,5), hypoxia (6,7), and pro-
inflammatory cytokines themselves (2,3) lead to the phos-
phorylation of the inhibitory protein of NF-kappa-B, in-
hibitory kappa-B (I-kappa-B), and p38 MAPK, thereby
promoting the expression of inflammatory genes. In adults
with heart failure, increased systemic and intramyocardial
synthesis of TNF-alpha has been discussed as a contributor
to sustained myocardial dysfunction (8). In contrast, the
natural anti-inflammatory cytokine IL-10 could, by deacti-
vation of macrophages and downregulation of pro-
inflammatory cytokines, contribute to myocardial protec-
tion, as shown in animal models by our group (9) and others
(10).
In infants with congenital cardiac defects, intramyocar-
dial cytokine synthesis could be stimulated by mechanical
stress (5), hypoxemia (11), and increased systemic cytokine
levels (12), but this question has not been addressed so far.
Therefore, this study was intended to test the hypothesis
that cytokines would be upregulated in the ventricular
myocardium of infants with congenital cardiac defects and
to identify the signaling pathways involved.
METHODS
Clinical. PATIENTS. After approval by the Human Ethical
Committee of the Aachen University of Technology and
obtainment of the parents’ informed consent, 15 infants age
1.5 to 11.5 months undergoing primary corrective surgery
were investigated. Seven patients had tetralogy of Fallot
(TOF) and eight had large ventricular septal defects (VSDs)
with pulmonary hypertension. All patients with TOF had a
mild degree of hypoxemia (arterial oxygen saturation [SaO2]
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90%), and all patients with VSD had a left-to-right shunt
50% with volume overload of the left ventricle. Intracar-
diac pressures were measured at cardiac catheterization. The
ratio between the right ventricular and left ventricular
systolic pressure (RVP/LVP) was used as an index for RVP
overload, independent of the patient’s age and degree of
sedation during cardiac catheterization. Three patients with
VSD had Down syndrome. None of the patients was
breastfed at the time of surgery. Patient data are shown in
Table 1.
Cardiac operation and sampling of myocardial biopsies.
In all cases, conventional general anesthesia consisted of
midazolam, fentanyl sulfate, and pancuronium bromide.
Dexamethasone (1 mg/m2 body surface area) was given
before the sternotomy. Before institution of cardiopulmo-
nary bypass (CPB), a right atrial biopsy was taken. After
institution of hypothermic CPB with a flow index of 2.7
l/min per m2 body surface area for 15 to 20 min, the aorta
was cross-clamped and cardiac arrest was instituted by
intra-aortal injection of 4°C cold cardioplegic solution
(Bretschneider, 30 ml/kg body weight), which was re-
aspirated in the right atrium. A right ventricular biopsy was
taken from the outflow tract immediately after aortic clamp-
ing under deep hypothermia (22°C) and low-flow bypass
(0.65 l/min per m2 body surface area). The time interval
between administration of dexamethasone and sampling of
ventricular biopsies averaged 91  14 min (mean  SEM)
and was similar in patients with TOF or VSD.
Biopsies taken for detection of messenger ribonucleic acid
(mRNA), measurement of protein levels, and analysis of
nuclear extracts were immediately snap-frozen in liquid
nitrogen and stored at 80°C until processed. Biopsies
taken for immunocytochemistry were fixed in B*5 buffer
(0.6% ZnCl2 and 0.1% acid acetate), embedded in paraffin,
and sectioned into 3-m thick sections.
Reverse transcriptase-polymerase chain reaction. Total
ribonucleic acid (RNA) was extracted from the atrial and
ventricular myocardium in all patients by using the RNeasy
kit (QIAGEN Inc., Hilden, Germany). The RNA (2 g)
was reverse-transcribed to complementary deoxyribonucleic
acid (DNA) with random hexamers. Complementary DNA
products were amplified by polymerase chain reaction (35
cycles; 94°C for 45 s, 60°C for 45 s, 72°C for 1 min) with
specific human primers for TNF-alpha, IL-10, and iNOS
(Clontech, Heidelberg, Germany). The polymerase chain
reaction products were subjected to electrophoresis in 1.8%
agarose gel and stained with ethidium bromide and photo-
graphed. The predicted lengths of the amplification prod-
ucts for TNF-alpha, IL-10, and iNOS were 444, 289, and
259 base pairs, respectively.
Western blotting. Isolated human adult monocytes stim-
ulated with 1 g/ml endotoxin (lipopolysaccharide by
Sigma, St. Louis, Missouri) (13) served as positive controls
and nonstimulated monocytes as negative controls. Total
protein homogenates (100 g) from the ventricular myo-
cardium taken in all patients and from monocytes were
denatured and separated on 12% and 8% polyacrylamide
gels by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis. Primary antibodies in immunoblotting were
monoclonal mouse anti-human TNF-alpha and IL-10
(R&D Systems, Wiesbaden-Norderstadt, Germany);
Abbreviations and Acronyms
EMSA  electrophoretic mobility shift assay
IL  interleukin
I-kappa-B  inhibitory kappa-B
iNOS  inducible nitric oxide synthase
LVP  left ventricular pressure
MAPK  mitogen-activated protein kinase
NF-kappa-B  nuclear factor kappa-B
RVP  right ventricular pressure
TNF  tumor necrosis factor
TOF  tetralogy of Fallot
VSD  ventricular septal defect
Table 1. Epidemiologic Data and Preoperative Hemodynamics
TOF Group (n  7) VSD Group (n  8) p Value
Gender (female/male) 2/5 4/4 NS
Age at cardiac catheterization (months) 4.7  0.8 4.5  0.6 NS
Age at operation (months) 6.8  1.4 6.6  0.8 NS
Weight at operation (g) 6,762.8  741.2 5,198.7  617.6 NS
Preoperative digoxin (n) 0 2 NS
RVP* (mm Hg) 69.1  5.4 62.6  5.5 NS
LVP* (mm Hg) 70.1  5.3 78.1  4.1 NS
RVP/LVP ratio* 0.98  0.01 0.79  0.05 0.005
PAP* (mm Hg) 15.0  9.0 30.7  3.3  0.1
L-R shunt* (%) — 71.6  3.6 —
LVEDP* (mm Hg) 8.00  1.53 8.88  0.72 NS
LAP* (mm Hg) 2.5  0.50 6.1  1.45 NS
RAP* (mm Hg) 2.2  0.8 3.6  0.7 NS
SaO2* (%) 88.8  2.55 95.2  1.22 0.03
Data are presented as the mean value  SEM. *At cardiac catheterization performed in patients breathing room air.
LAP  mean left atrial pressure; L-R  left to right; LVEDP  left ventricular end-diastolic pressure; LVP  systolic left
ventricular pressure; NS  not significant; PAP  mean pulmonary arterial pressure; RAP  mean right atrial pressure; RVP
 systolic right ventricular pressure; SaO2  arterial oxygen saturation; TOF  tetralogy of Fallot; VSD  ventricular septal
defect.
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monoclonal mouse anti-human phospho-I-kappa-B-alpha
(Ser32/36) (Cell Signaling Technology, Inc., Frankfurt am
Main, Germany); monoclonal mouse anti-human iNOS
(BD Transduction Laboratories, Heidelberg, Germany),
polyclonal rabbit anti-human phospho-p38 (Cell Signaling
Technology, Inc.), and monoclonal mouse antihuman beta-
actin (Sigma). The bands were detected by a chemilumi-
nescence system according to the manufacturer’s instruc-
tions (Amersham-Pharmacia, Freiburg, Germany). Protein
signals for TNF-alpha, IL-10, iNOS, phospho-I-kappa-B-
alpha, and phospho-p38 were normalized for beta-actin
signals that were developed on the same blotting (National
Institutes of Health [NIH] imaging 1.61b8. software, Bio-
Rad Laboratories Inc., Hercules, California).
Enzyme-linked immunosorbent assay (ELISA).
Cytokine concentrations in the ventricular myocardium
were assessed in all patients by using commercially available
ELISA kits for human TNF-alpha, IL-1-beta, IL-6, and
IL-10. Frozen tissue was homogenized in ice-cold Tris
buffer containing the following protease and phosphatase
inhibitors: pepstatin A (2 g/ml), leupeptin (5 g/ml),
aprotinin (5 g/ml), and phenylmethylsulfonyl fluoride
(PMSF) (1 mmol/l). After centrifugation at 13,000 rpm for
10 min, the samples were kept on ice for the duration of the
assay. Total protein levels were quantified using the Bio-
Rad protein assay (Bio-Rad Laboratories Inc.), with bovine
serum albumin (Sigma) as a standard. Tissue samples were
standardized to 1,000 g total protein in 100 l diluent
buffer for each determination. Standard reference cytokines
were provided by the manufacturer. Assays were done in
duplicate on a microtiter plate reader (wavelength 450 nm).
The assays have a high specificity for the measurement of
natural and recombinant human TNF-alpha, IL-1-beta,
IL-6 (Cytoscreen, BioSource International Inc., Camarillo,
California), and IL-10 (Endogen Inc., Woburn, Massachu-
setts). Values are reported as pg/ml of standardized sample,
which is equivalent to pg/1,000 g total protein.
Electrophoretic mobility shift assay (EMSA). In six un-
selected patients (3 in each group), nuclear extracts from the
ventricular myocardium were homogenized in hypotonic
buffer A (10 mmol/l H EPES/KOH at pH 7.9, 1.5 mmol/l
MgCl2, 10 mmol/l KCl, 1 mmol/l Na3VO4, 0.2 mmol/l
PMSF, 0.5 mmol/l dithiothreitol [DTT]) and incubated for
10 min at 4°C. After centrifugation, the pellet was resus-
pended with buffer C (20 mmol/l HEPES/KOH at pH 7.9,
420 mmol/l NaCl, 1.5 mmol/l MgCl2, 0.2 mmol/l EDTA,
25% (vol./vol.) glycerol, 1 mmol/l Na3VO4, 0.2 mmol/l
PMSF, 0.5 mmol/l DTT), incubated for 20 min at 4°C, and
centrifuged at 14,000 g for 2 min, yielding nuclear extracts
for further processing. Protein concentrations of nuclear
extracts were measured with the Bio-Rad protein assay. A
double-stranded oligonucleotide containing the consensus
binding motif for the transcription factor NF-kappa-B was
used: 5AGTTGAGGGGACTTTCCCAGG-3, 5-
TGCCTGGGAAAGTCCCCTCA-3 (MWG-Biotech
AG, Ebersberg, Germany). The oligonucleotide probe was
labeled by filling in 5-protruding ends with the Klenow
enzyme, using (alpha-32P)-adenosine triphosphate (ATP)
(10 mCi/ml, 3,000 Ci/nmol). For the supershift experi-
ments, nuclear extracts were preincubated with 4 g of
NF-kappa-B-p50 or -p65 (Santa Cruz Biotechnology, Hei-
delberg, Germany). The protein-DNA complexes were
resolved on a 5% polyacrylamide gel containing 7.5%
glycerol in 0.25-fold TBE (20 mmol/l Tris HCl [pH 8.0],
20 mmol/l boric acid, 0.5 mmol/l EDTA). Gels were dried
and autoradiographed.
Immunocytochemistry. Immunostaining was performed
using the immunohistochemistry rabbit or mouse kit
(InnoGenex, California) in four patients (2 in each group).
Briefly, endogenous peroxidase was blocked by hydrogen
peroxide. Sections were incubated with the primary anti-
bodies for 2 h at room temperature. Immunoreaction sites
were visualized with the use of the appropriate biotinylated
secondary antibodies and horseradish peroxidase-
steptavidin conjugate. Peroxidase activity was revealed with
a solution of aminoethyl carbazole to produce a red reaction
product, and sections were counterstained with Mayer’s
hematoxylin. Positive and negative controls were performed
by staining inflamed and noninflamed human tonsils, re-
spectively (not shown). In the myocardial probes, negative
controls were obtained by omitting the primary antibodies.
Typical morphologic characteristics for cardiomyocytes,
macrophages, and endothelial cells were assessed by using
oil microscopy at 1,000-fold magnification.
The following primary antibodies were used: monoclonal
mouse anti-human TNF-alpha and anti-IL-10 (all from
R&D Systems); polyclonal rabbit anti-human NF-kappa-
B-p65 and -p50 (Santa Cruz Biotechnology); and mono-
clonal mouse anti-human iNOS (BD Transduction Labo-
ratories).
Statistical analysis. Results are expressed as the mean
value  SEM. The Mann-Whitney U test was used to
analyze differences between groups. Correlation of indepen-
dent parameters was assessed by the Spearman rank corre-
lation test. A p values 0.05 was considered significant.
Data were analyzed with the Statistical Package for Social
Sciences (SPSS Software GmbH, Munich, Germany).
RESULTS
Clinical results. Table 1 summarizes the patients’ epide-
miologic data. Patients with TOF had a significantly higher
preoperative RVP/LVP ratio with significantly lower SaO2
than patients with isolated VSD (p  0.005 and p  0.03,
respectively).
Laboratory results. INTRAMYOCARDIAL SYNTHESIS OF
PRO- AND ANTI-INFLAMMATORY CYTOKINES. Cytokine
mRNA expression in the right atrium: both TNF-alpha and
IL-10-mRNA were detected in seven of seven and five of
seven patients with TOF and in seven of eight and four of
eight patients with VSD, respectively.
Cytokine mRNA expression in the right ventricle: only
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TNF-alpha-mRNA was detected in seven of seven patients
with TOF and in seven of eight with VSD.
Cytokine concentrations in the right ventricle: in all
patients, TNF-alpha, IL-1-beta, and IL-6 could be de-
tected by ELISA. Their concentrations were higher in
infants with TOF than in those with VSD (p  0.02, p 
0.05, and p  0.01, respectively) (Fig. 1). Western blotting
confirmed this by showing higher levels of TNF-alpha in
patients with TOF than in the others (p 0.05) (Fig. 2). In
contrast, levels of IL-10 measured by ELISA and Western
blotting were similar in both groups (Figs. 1 and 2).
Considering all patients, concentrations of TNF-alpha,
IL-1-beta, and IL-6 measured by ELISA correlated with
the RVP/LVP ratio (Spearman coefficient: 0.66 [p  0.05],
0.64 [p  0.05], and 0.68 [p  0.05], respectively). The
RVP/LVP ratio also correlated with the levels of TNF-
alpha measured by Western blotting (Spearman coefficient:
0.73 [p  0.002]) (Fig. 3). There was no correlation
between cytokine levels and left ventricular end-diastolic
pressure, left atrial pressure, degree of left-to-right shunt, or
SaO2.
Immunocytochemistry showed the presence of TNF-
alpha and IL-10 in cardiomyocytes, macrophages, and
endothelial cells. Figure 4 illustrates the localization of
TNF-alpha in cardiomyocytes and that of IL-10 in cardi-
omyocytes, macrophages, and endothelial cells.
Intramyocardial synthesis of iNOS. Inducible NOS-
mRNA was detected in the right atrial myocardium of all
patients. Levels of iNOS measured by Western blotting in
the ventricular myocardium were similar in patients with
TOF and in those with VSD (1.01  0.28 vs. 0.83  0.15,
respectively [p  NS]). Immunocytochemistry showed pos-
itive staining for iNOS in many cardiomyocytes (Fig. 4).
Activation of NF-kappa-B in the myocardium. The
DNA binding activity of NF-kappa-B was detected by
EMSA with supershift in the ventricular myocardium in all
patients investigated (Fig. 5). Levels of phosphorylated
I-kappa-B-alpha measured by Western blotting were sim-
ilar in patients with TOF and in those with VSD (Fig. 6).
Positive staining for NF-kappa-B-p50 and NF-kappa-B-
p65 was present in the cytoplasma and cell nucleus of
numerous cardiomyocytes (Fig. 4).
Phosphorylation of p38 MAPK in the ventricular myo-
cardium. Levels of phospho-p38 MAPK detected by
Western blotting were higher in patients with TOF than in
those with VSD (p  0.03) (Fig. 7). In all patients
investigated, they correlated with RVP/LVP (Spearman
coefficient: 0.58 [p  0.1]).
DISCUSSION
Presence of pro-inflammatory cytokines in the myocar-
dium of infants with congenital cardiac defects. Our
results provide evidence for the intramyocardial expression
of pro-inflammatory cytokines in infants with congenital
cardiac defects. The presence of cytokine-mRNA in the
atrial samples taken before CPB and the presence of
cytokines in the ventricular myocardium sampled after a
short period of hypothermic CPB, as well as after pretreat-
ment with dexamethasone (14), support the view that the
intramyocardial cytokine synthesis reported here was not
simply due to cardiac surgery.
In the present series, all patients showed chronic RVP
overload. Numerous experimental studies indicate that me-
chanical stress to the myocardium can induce the expression
of a variety of genes to which TNF-alpha belongs (5). This
supports our data suggesting an association between pres-
Figure 1. Levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1-beta, IL-6, and IL-10 measured by enzyme-linked immunosorbent assay in the
right ventricular myocardium of infants with tetralogy of Fallot (solid bar; n  6) or ventricular septal defect (open bar; n  6). Results are expressed as
the mean value  SEM. *p  0.02; †p  0.05; and ‡p  0.01 between groups.
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sure overload of the right ventricle and upregulation of
TNF-alpha in the myocardium. However, the role of other
stimuli in the induction of pro-inflammatory cytokines in
the myocardium is not excluded. Indeed, hypoxemia in
patients with TOF or congestive heart failure in patients
with VSD might also have contributed to cytokine upregu-
lation. Indeed, we have shown recently that the systemic
levels of pro-inflammatory cytokines are elevated in infants
with congenital cardiac defects compared with healthy
infants (12). In our patients, downstream cytokines such as
IL-1-beta and IL-6 were also over-expressed, suggesting
the activation of a hierarchical cytokine cascade initiated by
TNF-alpha and then sustained by IL-1-beta and IL-6.
Because these pro-inflammatory cytokines play a regulatory
role in cardiac remodeling (8,15) and possess strong cardiac-
depressant properties, they may contribute to the patho-
physiology of myocardial hypertrophy and failure in infants
with congenital cardiac defects. Furthermore, the presence
of these cytokines in the myocardium at the time of cardiac
surgery could well enhance the postoperative cytokine-
related myocardial damage we recently described (16).
Potential for anti-inflammatory balance in the infant
myocardium. A further major new finding of this study is
the presence of the anti-inflammatory cytokine IL-10 in the
myocardium of infants with congenital cardiac defects. This
indicates a potential for cytokine balance in this age group.
The fact that patients with TOF had similar intramyocar-
dial production of IL-10 despite of higher levels of pro-
inflammatory cytokines than patients with VSD suggests
altered cytokine balance in the former. This is in line with
our previous results showing that infants with TOF have
higher plasma levels of IL-6 but lower concentrations of
IL-10 than patients with heart failure (12). Inadequate
cytokine balance in patients with TOF might be the result
of the repression of IL-10 by chronic hypoxemia (17). In a
model of myocardial infarction, IL-10 was shown to be
predominantly produced by CD5-positive lymphocytes
Figure 2. (A) Levels of tumor necrosis factor (TNF)-alpha and interleukin
(IL)-10 measured by Western blotting in the right ventricular myocardium
of infants with tetralogy of Fallot (TOF) (solid bar; n  7) or ventricular
septal defect (VSD) (open bar; n  8). Band intensities for TNF-alpha
and IL-10 are normalized for bands of beta-actin. Results are expressed as
the mean value  SEM. *p  0.01 between groups. (B) Exemplary gels
obtained after Western blotting representative of seven experiments in
infants with TOF and eight experiments in infants with VSD, showing a
higher expression of TNF-alpha but not IL-10 in the former group. The
upper panel includes positive controls (PC) (human monocytes stimulated
with lipopolysaccharide) and negative controls (NC) (nonstimulated hu-
man monocytes). M  marker.
Figure 3. Relationship between the right ventricular pressure (RVP)/left
ventricular pressure (LVP) ratio and protein levels of tumor necrosis factor
(TNF)-alpha measured by Western blotting in all patients (n  15).
Spearman coefficient: 0.73 (p  0.002).
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(18). In our series, cardiomyocytes were overtly involved in
IL-10 synthesis. Because IL-10 inhibits TNF-alpha, IL-1-
beta, and IL-6 at the transcriptional level, mainly by
stimulating the production of I-kappa-B (19), and because
IL-10 may inhibit the activation of p38 MAPK (20), the
presence of IL-10 in the myocardium of infants with
congenital cardiac defects might indicate an adaptive mech-
anism to limit inflammation-related damage and/or
dysfunction.
Activation of the NF-kappa-B and p38 MAPK pathways
in the infant myocardium. Nuclear factor-kappa-B is a
transcription factor regulating numerous inflammatory
genes (2). Recent data suggest that, in adult patients, it
might play a key role in the pathophysiology of myocardial
ischemia/reperfusion injury and congestive heart failure
(2,21). The p38 MAPK cascade belongs to the signal
transduction pathways regulating stress responses, inflam-
mation, and apoptosis (3). Mechanical cell stress is one of
the common potential stimuli for the activation of both the
NF-kappa-B and p38 MAPK pathways (4). On stimula-
tion, several interactions take place between both pathways,
which could enhance the inflammatory response (3). In our
study, degradation of I-kappa-B-alpha and nuclear translo-
cation of NF-kappa-B in the ventricular myocardium sug-
gest NF-kappa-B activation, confirming the results of a
recent study performed in children with congenital cardiac
defects (22). Furthermore, our results give the first evidence
that the p38 MAPK cascade is also activated in the infant
myocardium. The fact that patients with TOF, who had the
highest production of pro-inflammatory cytokines, also had
the highest levels of phospho-p38 MAPK, as well as the
positive correlation between pressure overload of the RV
and levels of phospho-p38 MAPK, supports the view that
p38 MAPK might be of particular importance for the signal
transduction regulating inflammatory processes in response
to a mechanical stimulus to the infant myocardium.
Synthesis of iNOS in the myocardium of infants with
congenital cardiac defects. Because NF-kappa-B is re-
sponsible for TNF-alpha and IL-1-beta–mediated gene
expression of iNOS (23) and NO production in cardiomy-
ocytes is enhanced through p38 MAPK-mediated NF-
kappa-B activation (24), we expected synthesis of iNOS in
our patients. This was confirmed by our results, which go
along with those of a recent study where iNOS activity was
detected in the right atrial myocardium of children with
congenital cardiac defects (25). In that study, iNOS activity
was higher in cyanotic than in acyanotic children. In
contrast, in our series, the myocardial concentrations of
iNOS were not influenced by hypoxemia. The clinical
significance of upregulation of iNOS in the myocardium of
infants with congenital cardiac defects remains to be estab-
lished. However, a large body of evidence suggests that high
Figure 4. Immunocytochemistry of the right ventricular myocardium in one infant with tetralogy of Fallot, showing the presence of tumor necrosis factor
(TNF)-alpha in cardiomyocytes (My), interleukin (IL)-10 in cardiomyocytes, macrophages (M), and endothelial cells (EC), inducible nitric oxide synthase
(iNOS) in cardiomyocytes, and nuclear factor (NF)-kappa-B p50 and p65 subunits in the cytoplasma and nuclei of cardiomyocytes. C  negative control
(no primary antibody). Magnification: 400 for control, cytokines, and iNOS and 1,000 for NF-kappa-B p50 and p65 subunits. These stains are
representative of those obtained in four patients (two in each group).
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local concentrations of nitric oxide related to induction of
iNOS are associated with myocardial cell damage and cell
death (26). Nitric oxide mediates the so-called nitric oxide-
dependent acute negative inotropic and cytotoxic effects of
TNF-alpha, including disruption of calcium handling (27).
On the other hand, iNOS could also mediate protective
Figure 5. (A) Deoxyribonucleic acid (DNA)-binding activity of nuclear factor (NF)-kappa-B measured by EMSA with supershift in the right ventricular
myocardium of infants with tetralogy of Fallot (TOF) (solid bar) or ventricular septal defect (VSD) (open bar). Results are expressed as counts
(CNT)/mm2. (B) Exemplary gel showing the presence NF-kappa-B (arrow) detected by electrophoretic mobility shift assay and supershift with anti-p65
and anti-p50 in nuclear extracts of the right ventricular myocardium of one patient with TOF and one patient with VSD. This gel is representative of those
obtained in three patients from each group. PC  positive control (human HepG2 cells stimulated by TNF-alpha); NS  nonspecific.
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effects, as demonstrated in late myocardial ischemic precon-
ditioning (28), suggesting the importance of the nature and
timing of the inflammatory stress as to whether iNOS will
harm or protect the myocardium.
Further studies are therefore imperative to clarify the role
of chronic intramyocardial iNOS synthesis in infants with
congenital cardiac defects.
Conclusions. This study demonstrates, for the first time,
the synthesis of cytokines in the myocardium of infants with
congenital cardiac defects. Stimuli such as pressure overload
of the myocardium could upregulate pro-inflammatory cy-
tokines by activating, at least in part, the NF-kappa-B and
p38 MAPK pathways. Synthesis of the natural anti-
inflammatory cytokine IL-10 in the infant myocardium
might counterbalance the inflammatory pathways and could
be a potential target for future therapeutic interventions.
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ventricular septal defect (VSD) (open bar; n 5). Results of phospho-p38
MAPK are normalized for the bands of beta-actin and are expressed as the
mean value  SEM. *p  0.05 between groups. (B) Exemplary gel
obtained after Western blotting representative of five experiments in each
group, showing higher phosphorylation of p38 MAPK in the right
ventricular myocardium of patients with TOF than of those with VSD.
The upper panel includes the positive control (PC; human monocytes
stimulated with lipopolysacchardide). M  marker.
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